1. Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
   Chek Kun Tan et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
2. PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
   Hao Chen et al, 2023, Pharmacology & Therapeutics CrossRef
3. Antidiabetic Phytocompounds Acting as Glucose Transport Stimulators
   Mohamed Eddouks et al, 2023, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
4. A review on invasive false indigo bush (Amorpha fruticosa L.): Nuisance plant with multiple benefits
   Jasna Grabić et al, 2022, Ecology and Evolution CrossRef
5. Amorpha fruticosa – A Noxious Invasive Alien Plant in Europe or a Medicinal Plant against Metabolic Disease?
   Ekaterina Kozuharova et al, 2017, Frontiers in Pharmacology CrossRef
6. Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
   Jiashu Pan et al, 2022, Biomedicine & Pharmacotherapy CrossRef
7. A novel PPARα/γ agonist, propane-2-sulfonic acid octadec-9-enyl-amide, ameliorates insulin resistance and gluconeogenesis in vivo and vitro
   Tong Ren et al, 2018, European Journal of Pharmacology CrossRef
8. Identification of Antidiabetic Compounds from the Aqueous Extract of Sclerocarya birrea Leaves
   Vinesh Maharaj et al, 2022, Molecules CrossRef